Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 26, 2025 FORM 4
4 Mar 26, 2025 FORM 4
4 Mar 26, 2025 FORM 4
4 Mar 19, 2025 FORM 4
4/A Mar 5, 2025 FORM 4/A
4 Mar 5, 2025 FORM 4
4 Mar 5, 2025 FORM 4
4 Mar 5, 2025 FORM 4
4 Mar 4, 2025 FORM 4
8-K Mar 4, 2025 8-K
144 Mar 3, 2025
4 Feb 26, 2025 FORM 4
4 Feb 26, 2025 FORM 4
4 Feb 26, 2025 FORM 4
10-K Feb 26, 2025 10-K
8-K Feb 25, 2025 8-K
SCHEDULE 13G/A Feb 3, 2025
144 Jan 21, 2025
144 Jan 14, 2025
8-K Jan 10, 2025 8-K
SCHEDULE 13G/A Jan 8, 2025
5 Jan 6, 2025 FORM 5
4 Jan 6, 2025 FORM 4
SC 13G/A Nov 14, 2024 AMENDMENT NO. 2 TO SCHEDULE 13G
SC 13G Nov 7, 2024 ACQUISITION OF BENEFICIAL OWNERSHIP
← Newer Page 7 of 54 · 1328 filings Older →